ZUBSOLV is a prescription medication specifically designed for the treatment of opioid dependence within a comprehensive treatment plan that includes counseling and psychosocial support. It is a sublingual tablet, meaning it dissolves under the tongue, and combines two active ingredients: buprenorphine and naloxone. Buprenorphine is a partial opioid agonist, which helps alleviate withdrawal symptoms and cravings for opioids without producing the same high or dangerous side effects as other opioids. Naloxone is included to prevent misuse of the tablet form; if injected, naloxone will block the effects of opioids, potentially causing withdrawal symptoms in a person with opioid dependence. ZUBSOLV is intended to be part of a medical, social, and psychological treatment program to help individuals reduce or quit their use of heroin or other opiates, such as prescription pain relievers.
Your cart contains products from a separate order category. Adding this product will remove those items from your cart.
Important Supply & Pricing Update about GLP-1 Medications
Due to manufacturer-driven price increases from Eli Lilly and other suppliers, prices for GLP-1 medications including Mounjaro have risen significantly. Global supply constraints may also result in slightly longer lead times.
We remain committed to securing the best possible pricing and supply for our customers and will continue to provide updates as the situationĀ evolves.